Skip to main content
Our news
View moreView more
Dr. Richard Furie, professor at The Feinstein Institutes for Medical Research, will publish and present data describing the clinical benefit of anifrolumab for patients at the American College of Rheumatology’s Annual Scientific Meeting.
The genetic research study, MapYourHealth is expanding the diversity of existing data.
Feinstein Institutes researchers complete phase 3 trial of the drug difelikefalin, which shows results of improved itch-related quality of life for patients undergoing dialysis.
The Feinstein Institutes for Medical Research helped develop a light-weight, wearable sleeve that regulates individual finger forces to facilitate movement in paralyzed individuals.
Media coverage
View moreView more
Media coverage highlighting Dr. Steven Fishbane's discovery.
Verdict Medical Devices covers the latest development from the Feinstein Institutes.
In The Atlantic, Michael Birnbaum, MD, says increased activity reflects a shift in behavior, which could be a sign of an upcoming psychotic break.
Feinstein Institutes for Medical Research President and CEO Kevin J. Tracey, MD, looks at the future of health care in an interview with Authority Magazine.

The Feinstein Institutes for Medical Research is a place where imaginative thinking, innovation and inquiry meet persistence, commitment and collaboration. 

View the annual report